SUMMARY We describe the inherited folate sensitive fragile site, fra(2)(ql3), in three unrelated mentally retarded children, two of them with different forms of epilepsy. Fra(2)(ql3) was detected in one healthy sib of one of the probands. Except for one cell in one of the fathers, fra(2)(ql3) could not be detected in any of the six parents, who were repeatedly studied using methods known to induce fragile sites of this type. These findings suggest that fra (2)(ql3) is not associated with the clinical features of our patients and can be transmitted by persons not expressing it. The expression of fra (2) In other words, whenever a fragile site is observed in a subject, one parent is also found to have it if adequately studied. Exceptions to this rule are discussed below. This report describes three probands with fra(2)(ql3) in whose parents the fragile site was not demonstrable (except for one cell in one father). A sib of one of the probands had the fragile site, indicating that in at least one of the families it must have been transmitted by a parent not expressing it. We discuss these findings with special reference to the clinical features that prompted the investigation of the probands.
A fragile site is a non-staining gap which is always in the same place in the chromosome. The gap is of variable width and usually involves both chromatids. [1] [2] [3] Fragile sites are classified into four main categories4 5: folate sensitive, distamycin A inducible, BrdU inducible, and common fragile sites. Unlike the others, the latter are not necessarily heritable. The heritable fragile sites have a tendency to produce acentric chromosome fragments, triradial figures, and chromosome deletions at the site of the fragility.' Like other chromosomal polymorphisms the heritable fragile sites are transmitted in a dominant fashion.2 Half of the offspring of a carrier will receive the chromosome with the fragile site. New mutations have not been convincingly documented.2 In other words, whenever a fragile site is observed in a subject, one parent is also found to have it if adequately studied. Exceptions to this rule are discussed below. This report describes three probands with fra(2)(ql3) in whose parents the fragile site was not demonstrable (except for one cell in one father). A sib of one of the probands had the fragile site, indicating that in at least one of the families it must have been transmitted by a parent not expressing it. We discuss these findings with special reference to the clinical features that prompted the investigation of the probands.
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Methods
Chromosome analyses were performed on mitoses obtained from lymphocyte cultures (0(5 ml whole blood in 8 ml medium). Four different types of culture medica and methods were used, as follows. (1 was added and the incubation continued for 24 hours. All media contained 50 U/ml penicillin, 50 [tg/ml streptomycin, 3-75 tg/ml L-glutamine (Gibco), and 3 75 [tg/ml leucoagglutinin (Pharmacia, Finland) . Colemid (Gibco), at a concentration of 0( 125 [tg/ml, was present for the last hour of incubation.
The cells were treated with hypotonic solution, fixed, and stained using conventional methods. Trypsin was used to obtain G banding.
Patients
Proband 1 is a 12 year old girl with mild mental retardation and epilepsy. She is the oldest of three children. Her parents and two younger sisters are healthy. A paternal aunt has grand mal epilepsy. group.bmj.com on June 15, 2017 -Published by http://jmg.bmj.com/ Downloaded from mitoses in which other fragile sites and gaps occurred in these cultures. In as much as these figures reflect the levels at which fragile sites in general were induced in the cultures, it appears that the cultures were appropriate in this respect. Banding showed that in each of the three probands the fragile site was in 2q13 rather than in 2qll (fig 1) .
One metaphase from the father of proband 2 deserves special comment. In the methotrexate culture from this subject, one metaphase did show a fra (2)(q13). Even though the chromosomes were not banded, and even though the fragility did not necessarily appear to involve both chromatids ( fig  2) , our interpretation is that this represents fra (2)(q3).
Blood group studies (table 2) were compatible with paternity in families 1 and 2. In family 3 blood group studies were not performed but the size of the Y chromosome was the same in father and son, which is compatible with paternity.
Discussion
The indication for chromosome study using folic acid deficient medium was mental retardation in all three patients. The results initially raised the question of whether the observed de novo fragile site might be aetiologically related to the clinical abnormalities. Lejeune et a16 described a mother and daughter, both with borderline intelligence, with an unstable secondary constriction in the long arm of chromosome 2. Ferguson-Smith7 described a family with fragility of chromosome 2 in three generations. The fra (2) was found in three subjects with hyperlipoproteinaemia and in two normal subjects. None of the persons was mentally retarded. Later Williams and Howell8 described a mentally retarded patient with a secondary constriction in the proximal part of the long arm of chromosome 2 that might have been a fra(2)(q13). No fragility was found in either parent or a sister of the patient. Anneren and Gustavson9 also described a fragile site in the proximal part of the long arm of chromosome 2 in four probands with different clinical features: a boy with cardiomyopathy, a girl with malformations of the central nervous system (neither set of parents had abnormalities of chromosome 2), one mentally retarded boy (whose father had no fra(2); the mother was not examined), and a mentally retarded girl whose healthy mother had fra(2q).
Two different fragile sites very close to each other occur in chromosome 2, fra(2)(ql 1) and fra(2)(q13). Both are rare, folate sensitive fragile sites according to the classification of Sutherland and Hecht."' In the papers quoted above,"9 the precise localisation of the fragile site was not stated, so it is not known which of the two areas was involved in each case.
Gilgenkrantz et all' identified a fra(2)(qll) in a girl with familial lymphohistiocytosis. The fragile site of our probands was in 2q13, clearly more distal than the 2qll fragile site described by Gilgenkrantz et al. 1 The fact that one healthy sister of our proband 1 showed fra(2)(ql3) suggests two interpretations. Firstly, one of the parents must have transmitted the fragile site to both children. This indicates that persons not expressing the fra(2)(ql3) can transmit it and raises the possibility that the expression of fra (2)(ql3) is age dependent. In this respect, the fra(2)(qI3) behaves in a fashion similar to fra(X)(q27). 12 If this hypothesis could be confirmed by the study of more families with fra(2)(ql3) and perhaps other autosomal fragile sites, it would help remove uncertainties as to the regular inheritance of these chromosomes. Secondly, our findings suggest that the fra(2)(q 13) is unrelated to the developmental disorders of our probands. This hypothesis could be tested by clinical and cytogenetic studies of other families in which fra (2)(ql3) 
